Fundraising FoxHealthtech Startups
18,751 companies tagged Healthtech, with their investors and founders.
0 investors
Courage Therapeutics is a neuroendocrine biotech developing MC4R agonist drugs for genetic obesity; its lead candidate CTX-B is a weekly injectable targeting melanocortin-4 receptor haploinsufficiency (MC4R HI), a form of early-onset severe obesity with no approved targeted therapy. The company translates research on the melanocortin system into therapeutic candidates for patients with MC4R pathway-driven obesity in the US.
0 investors
0 investors
0 investors
32 Biosciences develops gastrointestinal therapeutics that target gut microbial and host-microbe biology, with a lead candidate aimed at preventing surgical site infections in high-risk GI surgery. It uses a functional metabolomics discovery platform to support biomarkers, patient stratification, and drug discovery.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
CQens designs devices and methods that heat plant-based and medicant-infused formulations to produce aerosols for inhalation, with a focus on harm reduction. The company operates in Nevada and California, holding a portfolio of 111 US and international patents.
0 investors
0 investors
Creative Medical Technology Holdings (CELZ) is a biotechnology company developing regenerative medicine and immunotherapy platforms for conditions in immunology, endocrinology, urogynecology, and orthopedics. Its technologies include autologous immunotherapy (ImmCelz), an allogenic cell platform (AlloStem), a cellular reprogramming platform (iPSCELZ), and rapid autologous therapy programs (StemSpine, OvaStem, CaverStem).
0 investors
Credence MedSystems develops drug delivery and medical device technologies for pharmaceutical manufacturers and healthcare providers. The company is led by executives with extensive backgrounds in medical technology commercialization and surgical device innovation.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Crossover is a stealth-mode medical device company developing two Class II (510(k) pathway) implant systems for ankle fracture fixation, specifically fibular nailing and syndesmosis repair. It targets the US lower-extremity trauma fixation market and is building the devices with an acquisition-oriented strategy for strategic orthopedic partners and surgeon advisors.
0 investors